A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM and shown that blocking this molecule could delay the onset of the disease and significantly slow its progression.  The team state that they have identified the … Continue reading New treatment blocks progression of mutliple sclerosis in animal model.